Woman endured 11 years of chemotherapy for cancer she never had

Becky Jones was 21 years old when a consultant at University Hospital Coventry told her she had a terminal brain tumour and would need chemotherapy for the rest of her life to survive. She had recently met her partner Pete at work, was building a career as a CCTV operator, and suddenly the ground shifted beneath her. For the next eleven years, she took the chemotherapy drug temozolomide—far longer than standard treatment guidelines recommend. The drug ravaged her body: constant nausea, stomach pain, mouth ulcers, relentless fatigue. She avoided social events and family gatherings out of fear of infection. Her driving licence was taken away, then restricted. She was told she could never have children. The couple adjusted their entire life around her illness, cancelling meals out, abandoning the gym routines they loved. Every day felt precarious, lived under the weight of a death sentence.

Then in 2024, a doctor called to say her chemotherapy was stopping. No explanation. No transition plan. No new oncologist's name. The consultant who had diagnosed her, Prof Ian Brown, had retired—and Jones only learned this from the phone call ending her treatment. She was left adrift, unsupported by the hospital, uncertain what came next.

In May 2025, after independent analysis by neurosurgeons and radiologists commissioned by her lawyers, Jones received the answer that would reshape everything: she never had cancer. The brain inflammation she actually had—a condition called tumefactive demyelination—could have been treated with steroids by a neurologist. Eleven years of chemotherapy had been unnecessary. When the news came through on a video call with her solicitors and the medical experts, there were tears in everyone's eyes.

Jones is one of more than 40 patients now taking legal action against University Hospitals Coventry and Warwickshire NHS Trust. A preliminary review by the Royal College of Physicians examined 20 cases connected to Prof Brown and found 15 were "unsatisfactory overall." Patients were given prolonged courses of temozolomide with "little or no evidence of benefit." The review noted "scant evidence" that risks were understood or documented. One patient believed the drug had caused infertility. Another developed leukaemia after 100 unnecessary cycles. The review described the pattern as a "betrayal of patient trust" and questioned why pharmacy teams never challenged a consultant prescribing oral chemotherapy continuously for a decade or more.

The consultant did not participate in the review. The BBC attempted to contact Prof Brown multiple times but was unable to reach him. Fiona Tinsley, a lawyer representing many of the affected patients, explained that Brown had diagnosed Jones with grade four glioblastoma—one of the most aggressive brain cancers—before the results of her biopsy had even returned. When Jones questioned multiple scans that showed no visible tumour, she was told it would not be "visible to the naked eye."

Jones described the preliminary findings as "chilling." "It's not just about what he's done," she said. "It's about how they let him act on his own for so long. It's almost like he was running his own show and no one was there to monitor what he was doing." The review found insufficient clinical curiosity in some cases and a lack of collaboration with multidisciplinary team colleagues—the kind of oversight that might have caught the diagnostic error years earlier.

University Hospitals Coventry and Warwickshire said it would not comment on individual cases but stated that measures had been put in place to ensure "more robust oversight of the prescription and use" of the drug. The trust said all affected patients had been reviewed by senior clinicians with appropriate care plans established. It is also undertaking an independent review of its speak-up processes to ensure staff feel supported in raising concerns. The full Royal College of Physicians review is still pending, and the trust said it will take further action based on its findings.

For Jones, now 33 and a mother of two—children she was told would be miracles if they came at all—the damage is done. She has lost more than a decade of her adult life to a treatment she never needed. The question now is what accountability looks like, and whether the systems meant to protect patients can be rebuilt to prevent this from happening again.